Medical Marijuana, Inc. (OTCPK:MJNA) released financial results for the quarter ending June 30, revealing net revenue of $7.8 million, a decrease of 18.75% compared to 9.6 million in Q2 2021.
Q2 2022 Financial and Operational Highlights
Gross profit for the period ending June 30, 2022, was $6 million.
Gross margins for the period were 76%.
“We continue to lead the industry as a pioneer in the space by focusing our business on international market expansion,” stated Medical Marijuana, Inc. CEO Blake Schroeder. “We have first mover advantage in nearly every market where the …